
Jianmin Pharmaceutical Group Co., Ltd. — Investor Relations & Filings
Jianmin Pharmaceutical Group Co., Ltd. is a specialized pharmaceutical enterprise with a heritage dating back to 1637. The company focuses on the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and modern healthcare products. Its core portfolio emphasizes pediatric health, gynecological treatments, and chronic disease management. Key products include Longmu Zhuanggu Granules, recognized for supporting bone development and overall health in children. The group integrates traditional pharmacological wisdom with contemporary biotechnology and standardized production processes. Jianmin Group operates through a comprehensive value chain encompassing raw material sourcing, advanced manufacturing, and a distribution network. By leveraging its status as a time-honored brand, the company maintains a strong market position in the pediatric TCM segment while expanding its presence in general wellness and prescription drug markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 健民集团独立董事工作制度(2023年修订) | 2023-12-08 | Chinese | |
| 健民集团董事会薪酬与考核委员会实施细则(2023年修订) | 2023-12-08 | Chinese | |
| 健民集团董事会提名委员会实施细则(2023年修订) | 2023-12-08 | Chinese | |
| 健民集团股东大会议事规则(2023年修订) | 2023-12-08 | Chinese | |
| 健民集团董事会审计委员会实施细则(2023年修订) | 2023-12-08 | Chinese | |
| 健民集团关于修改《公司章程》部分条款的公告 | 2023-12-08 | Chinese |
Browse filings by year
23 years- 2026 38 filings
- 2025 67 filings
- 2024 77 filings
- 2023 101 filings
- 2022 128 filings
- 2021 146 filings
- 2020 105 filings
- 2019 80 filings
- 2018 85 filings
- 2017 78 filings
- 2016 85 filings
- 2015 106 filings
- 2014 58 filings
- 2013 65 filings
- 2012 38 filings
- 2011 40 filings
- 2010 51 filings
- 2009 46 filings
- 2008 27 filings
- 2007 37 filings
- 2006 42 filings
- 2005 24 filings
- 2004 35 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 41819789 | 健民集团独立董事工作制度(2023年修订) | 2023-12-08 | Chinese | ||
| 41819781 | 健民集团董事会薪酬与考核委员会实施细则(2023年修订) | 2023-12-08 | Chinese | ||
| 41819770 | 健民集团董事会提名委员会实施细则(2023年修订) | 2023-12-08 | Chinese | ||
| 41819760 | 健民集团股东大会议事规则(2023年修订) | 2023-12-08 | Chinese | ||
| 41819748 | 健民集团董事会审计委员会实施细则(2023年修订) | 2023-12-08 | Chinese | ||
| 41819741 | 健民集团关于修改《公司章程》部分条款的公告 | 2023-12-08 | Chinese | ||
| 41819731 | 健民集团关于召开2023年第二次临时股东大会的公告 | 2023-12-08 | Chinese | ||
| 41819715 | 健民药业集团股份有限公司章程(2023年修订) | 2023-12-08 | Chinese | ||
| 41819702 | 健民集团关于健民集团叶开泰智能制造基地建设与扩产升级项目(二期)建设的公告 | 2023-11-16 | Chinese | ||
| 41819692 | 健民集团第十届董事会第十八次会议决议公告 | 2023-11-16 | Chinese | ||
| 41819683 | 健民集团关于增加自有闲置资金现金管理额度的公告 | 2023-10-30 | Chinese | ||
| 41819671 | 健民集团第十届董事会第十七次会议决议公告 | 2023-10-30 | Chinese | ||
| 41819663 | 健民集团关于向中国人口福利基金会捐赠的公告 | 2023-10-30 | Chinese | ||
| 41819651 | 健民集团第十届监事会第八次会议决议公告 | 2023-10-20 | Chinese | ||
| 41819641 | 健民集团关于小儿紫贝宣肺糖浆获批上市的公告 | 2023-10-20 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Jianmin Pharmaceutical Group Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57130/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57130 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57130 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57130 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57130}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jianmin Pharmaceutical Group Co., Ltd. (id: 57130)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.